GE takes steps to solidify EU PET development, distribution
GE Healthcare has formed a manufacturing agreement with Advanced Accelerator Applications, a pharmaceutical company based in Milan, Italy, and focused on molecular nuclear medicine.
In combination with GE’s existing TracerNET network, the new partnership will provide additional capability of proprietary PET tracer production to a cumulative total of 20 sites and initial coverage in 11 countries. This agreement is GE’s first step toward establishing a pan-European PET distribution network over the next few years, according to the company.
Currently, GE said it has 15 tracers in various stages of development in its PET portfolio.
In combination with GE’s existing TracerNET network, the new partnership will provide additional capability of proprietary PET tracer production to a cumulative total of 20 sites and initial coverage in 11 countries. This agreement is GE’s first step toward establishing a pan-European PET distribution network over the next few years, according to the company.
Currently, GE said it has 15 tracers in various stages of development in its PET portfolio.